A Randomized Controlled Trial of In-Home Tele-Behavioral Health Care Utilizing Behavioral Activation for Depression
Technical Report,28 Feb 2011,27 Feb 2016
The Geneva Foundation Tacoma United States
Pagination or Media Count:
Evidence of feasibility, safety, and effectiveness of home-based telebehavioral health HBTBH needs to be established before adoption.The purpose of this randomized controlled non-inferiority trial was to compare the safety, feasibility, and effectiveness of HBTBH to careprovided in the traditional in-office setting among military personnel and veterans. One hundred and twenty one U.S. military servicemembers and veterans were recruited at a military treatment facility and a Veterans Health Administration VHA hospital. Participants wererandomized to one of two groups to receive either eight sessions of behavioral activation treatment for depression BATD in the home viavideoconferencing VC or in a traditional in-office setting. Participants were assessed at baseline, mid-treatment, post-treatment and 3months post treatment. Mixed-effects modeling suggested relatively strong and similar reductions in hopelessness and depressivesymptoms for both groups however, non-inferiority analyses failed to reject the null hypothesis that in-home care was no worse than inofficetreatment based on these measures. There were not any differences found between treatment groups in regards to treatmentsatisfaction, and safety procedures were successfully implemented. BATD can be feasibly delivered to the homes of active duty servicemembers and veterans via VC. Small group differences suggest a slight benefit of in-person care over in-home telehealth on some clinicaloutcomes.